-
Hospitals are searching for more pharmacists this year
Compared to 2022, there is a 15% higher demand for hospital pharmacists so far in 2023, according to a recent report from the American Association of Colleges of Pharmacy. -
Pfizer to close New Jersey site, relocate nearly 800 workers
Pfizer is shuttering its location in Gladstone, N.J., and the company is offering to relocate the current employees. -
Cleveland Clinic to employ drug-delivery drones
Cleveland Clinic is the latest health system to invest in drones that deliver prescription medications to patients' homes. -
An estimated 4,500 participating in CVS, Walgreens walkouts: 5 updates
Organizers estimate as many as 4,500 pharmacists and pharmacy technicians at CVS, Rite Aid and Walgreens are participating in a three-day walkout that began Oct. 30. -
American Pharmacists Association CEO calls for change amid Walgreens, CVS walkouts
Michael Hogue, PharmD, CEO and executive vice president of the American Pharmacists Association, has issued a statement of support for the planned walkouts by Walgreens and CVS pharmacy employees that began Oct. 30. -
Another Ozempic side effect pops up: 5 updates
The FDA label for Ozempic does not mention muscle pain, but some patients taking the popular Type 2 diabetes drug for weight loss are experiencing the side effect, according to an Oct. 27 report in women's magazine First for Women. -
FDA advisers favorable to 1st CRISPR gene therapy
A panel of FDA advisers concluded after hours of discussion Oct. 31 that the first CRISPR gene therapy candidate is safe enough for clinical use, The New York Times reported. -
Details fuzzy as CVS, Walgreens walkouts set to start
'Pharmageddon' is the nickname for a planned walkout by pharmacists at U.S. drugstore chains set to begin Oct. 30, although there is no count for how many workers will participate. -
FDA approves Eli Lilly's ulcerative colitis drug
Drugmaker Eli Lilly announced Oct. 26 that Omvoh, its ulcerative colitis medication, has received approval from the FDA. -
Sanofi to spin off consumer health division
Sanofi said it plans to separate from its consumer healthcare business — a move the company says will allow it to focus more on creating "transformative medicine and vaccines." -
FDA warns 2 drugmakers for selling probiotics to hospitals
After the FDA told hospitals to not give preterm infants probiotics following one baby's death, the agency sent warning letters to Abbott Laboratories and Infinant Health. -
Novartis, FDA confirm shortage over for prostate cancer drug
The FDA declared the shortage resolved for Pluvicto, a prostate cancer drug made by Novartis. -
Hospitals prepare for national drug take back day
Hospitals and health systems across the nation are among thousands of healthcare facilities participating in the Drug Enforcement Agency's National Prescription Drug Take Back Day on Oct. 28. -
Pfizer's flu and COVID combo shot shows positive early results
A combined phase 1 and 2 clinical trial of Pfizer's mRNA flu and COVID-19 combination vaccine have yielded positive results, the company announced Oct. 26. -
Flu shot could reduce risk of Alzheimer's, related dementias
A growing pile of research is finding a positive correlation between vaccinations and a reduced risk of Alzheimer's disease and related dementias, The Washington Post reported Oct. 26. -
MedStar researchers 'mine' for drug errors with machine learning
Most "close calls" of medication errors are not analyzed because most organizations manually review mistakes that lead to patient harm. Researchers at Columbia, Md.-based MedStar Health used machine learning to fix this lack of insight. -
Exela, Civica recall 3 drugs sent to health systems
Exela Pharma Sciences is pulling three medications, including one Civica brand, because silicone was found in samples during routine inspection, the FDA said Oct. 25. -
COVID-19, flu shots might raise stroke risk for older Americans: Preprint
The risk of a stroke was more prevalent for older adults who received a flu and bivalent COVID-19 vaccine within six weeks of the other in fall 2022, according to a preprint of research conducted by the FDA and CMS. -
8 drugs now in shortage
Monthslong drug shortages have affected quality in surgery, emergency care and other hospital departments in 2023, according to a recent survey of 200 healthcare workers. Recently, eight more medications have fallen into short supply or discontinuation. -
New York system taps pharmacy director
A three-hospital system in Oswego, N.Y., filled its pharmacy director position with Sarah Driscoll, PharmD, who has been in the role in an interim capacity since June.
Page 45 of 50